Article
Public Cord Blood Banks as a source of starting material for clinical grade HLA-homozygous induced pluripotent stem cells.
2022-05-23
Abstract excerpt
<title>Abstract</title> <p><underline>Background:</underline> The increasing number of clinical trials for induced pluripotent stem cell (iPSC)-derived cell therapy products makes the production on clinical grade iPSC more and more relevant and necessary. Cord blood banks (CBB) are an ideal source of young, HLA-typed and virus screened starting material to produce HLA-homozygous iPSC lines for wide immune-compati...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 782d370e-5694-560b-b152-6d3636fcea33
- DOI
- 10.21203/rs.3.rs-1664572/v1
